CBD Life Sciences Inc. (OTCMKTS:CBDL) Sees Significant Decline in Short Interest

CBD Life Sciences Inc. (OTCMKTS:CBDL) was the recipient of a large drop in short interest in December. As of December 31st, there was short interest totalling 39,500 shares, a drop of 88.3% from the December 15th total of 338,600 shares. Based on an average trading volume of 75,074,700 shares, the days-to-cover ratio is currently 0.0 days.

CBD Life Sciences Stock Performance

CBDL traded up $0.00 during midday trading on Wednesday, reaching $0.00. 17,508,873 shares of the company’s stock were exchanged, compared to its average volume of 20,930,363. CBD Life Sciences has a 1-year low of $0.00 and a 1-year high of $0.03.

CBD Life Sciences Company Profile

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.